Sovicell’s experienced team offers state-of-the-art services for drug development which includes access to all of our products, on a fee-for-service basis. Our TRANSIL technology platform and SOVICYTE cells and cell culture products enable us to reliably assess the in vitro ADMET profiles of pharmaceutical drug candidates. Major pharmaceutical companies have adopted our TRANSIL technology and we are continually developing services in collaboration with our customers to meet their needs.
The most recent additions to our services include a blood-to-brain absorption test that is based on true biological membranes and is proving invaluable in CNS drug research and development, as well as highlighting side effects in other therapeutic areas.
The Sovicell service advantage:
To find out further information or to receive advice about your specific needs, please contact our dedicated contract research team: service@sovicell.com.